Chemokine CCL2 can recruit monocytes with highly expressed CCR2, while targeted inhibition of CCR2 can decrease the recruitment of M2 macrophages and induce tumor infiltration of activated CD8+ T cells [8]. The gene discussed is CCR2; the disease is neoplasm.